Earlier, less-invasive treatment is at the core of the latest iteration of the joint European Society of Cardiology/European ...

The data do, however, hint at the benefit of a more tailored approach focusing on groups with higher bleeding risks.

Mamas Mamas talks to Jacob Thomsen Lønborg about how PCI affects outcomes for patients with stable CAD undergoing TAVI.

The REFINE-ICD results highlight the need to find better ways to identify at-risk patients who might benefit, one expert says ...

Though other types of diet could be used to stave off diabetes, Salas-Salvadó said the Mediterranean diet—with a focus on ...

MADRID, Spain—Baxdrostat (AstraZeneca), an investigational aldosterone synthase inhibitor, provides substantial reductions in blood pressure when added to background therapy in patients with ...

Whether it’s via an online program or simply a smartwatch, healthcare professionals stand to gain skills and insights.

Treatment with digitoxin cut the absolute risk of all-cause mortality and hospitalization for worsening HF by 4.6% compared with placebo over a median follow-up of 36 months (HR 0.82; 95% CI 0.69-0.98 ...

The user-friendly approach helped diabetic patients get A1c levels under control and reduce the number of prescribed ...

With 10 Hotline sessions, and 42 late-breaking science sessions, there is no shortage of new data for the practicing ...

It’s the first PCSK9 inhibitor to get the FDA’s approval for reducing MACE in patients without established cardiovascular ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...